Part A: healthy part B: overweight or obesity

Clinical trials for Part A: healthy part B: overweight or obesity explained in plain language.

Never miss a new study

Get alerted when new Part A: healthy part B: overweight or obesity trials appear

Sign up with your email to follow new studies for Part A: healthy part B: overweight or obesity, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New Weight-Loss pill enters human testing

Disease control Completed

This early-stage trial tests the safety of a new oral drug, IBI3032, in 104 people. Part A gives a single dose to healthy volunteers, while Part B gives multiple doses over 4 weeks to people with overweight or obesity. The goal is to check for side effects and how the drug moves …

Matched conditions: PART A: HEALTHY PART B: OVERWEIGHT OR OBESITY

Phase 1 • Sponsor: Innovent Biologics Technology Limited (Shanghai R&D Center) • Aim: Disease control

Last updated Sep 13, 2026 00:00 UTC

Part A: healthy part B: overweight or obesity

Get alerted when new Part A: healthy part B: overweight or obesity trials appear

New Weight-Loss pill enters human testing